欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号LV/H/0199/001
药品名称Ambrolytin 6 mg/ml syrup
活性成分
    • ambroxol hydrochloride 6.0 mg/ml
剂型Syrup
上市许可持有人Sopharma AD 16 Iliensko Shosse Str. Sofia, 1220 Bulgaria
参考成员国 - 产品名称Latvia (LV)
Ambrolytin 30 mg/5 ml sīrups
互认成员国 - 产品名称
    • Poland (PL)
      Ambrolytin max
    • Estonia (EE)
      AMBROLYTIN
    • Bulgaria (BG)
    • Lithuania (LT)
      Amrex 30 mg/5ml sirupas
许可日期2020/09/04
最近更新日期2024/08/09
药物ATC编码
    • R05CB06 ambroxol
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase